More Paradigm Biopharmaceuticals Ltd. news
Paradigm Biopharmaceuticals Ltd.ASX: PAR

Continuation of Voluntary Suspension

Sep 27, 2026 at 8:06 PM EDT · Issued by Paradigm Biopharmaceuticals Ltd.

Filed with ASX · Sep 27, 2026 at 8:06 PM EDT · 1 page · English

On 6ix: 6ix.com/news/continuation-of-voluntary-suspension-1

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

  • Agreement to Return US$2M to ObsidianSep 24
  • Notification of cessation of securities - PARSep 24
  • Phase 3 Interim Result Below Continuation ThresholdSep 23
  • Suspension from QuotationSep 22
  • Trading HaltSep 20

Later from Paradigm Biopharmaceuticals

  • Board Initiates Voluntary AdministrationSep 29
  • Appointment of Voluntary AdministratorsSep 29
  • Continuation of Suspension from QuotationSep 29
  • Update on Data Review and Convertible note redemptionOct 8
  • Expiry of PAROB Listed OptionsOct 12
All Paradigm Biopharmaceuticals news releases↗

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer